X-Nico

3 unusual facts about Hubert Schoemaker


Hubert Schoemaker

ReoPro was to be followed in August 1998 by the approval of Centocor's Remicade, a drug to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis.

Declining a position to work as a post-doctoral researcher with Stanley Cohen, the co-developer of recombinant DNA, Schoemaker entered the world of business.

Paul J. H. Schoemaker

His brother Hubert Schoemaker was a co-founder and the president of the biotech company Centocor.



see also